BARCLAYS PLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$438
+22.0%
145,9990.0%0.00%
Q2 2023$359
+987.9%
145,999
+884.0%
0.00%
Q1 2023$33
-17.5%
14,838
+28.7%
0.00%
Q4 2022$40
-100.0%
11,527
+62.3%
0.00%
Q3 2022$263,000
-17.0%
7,101
-57.5%
0.00%
Q2 2022$317,000
+589.1%
16,699
+882.3%
0.00%
Q1 2022$46,0001,7000.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders